SKIN FIBROSIS

Clinical trials for SKIN FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new SKIN FIBROSIS trials appear

Sign up with your email to follow new studies for SKIN FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could blocking TL1A stop skin scarring in scleroderma? early lab study hints at possibility

Knowledge-focused Not yet recruiting

This study will test if blocking a protein called TL1A can reverse skin scarring in systemic sclerosis, a rare autoimmune disease. Researchers will take blood and skin samples from 10 patients with early diffuse scleroderma and 10 healthy people. They will treat the samples in th…

Matched conditions: SKIN FIBROSIS

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:07 UTC

SKIN FIBROSIS

Get alerted when new SKIN FIBROSIS trials appear

Could blocking TL1A stop skin scarring in scleroderma? early lab study hints at possibility